Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$2.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Dec 15, 2025 |
| RLMD |
| Relmada Therapeutics, INC. |
| PBUY |
| 11,665 |
| $4.12 |
| $48.1K |
| +1.5% |
| Open the original filing on SEC.gov |
| Dec 12, 2025 | RLMD | Relmada Therapeutics, INC. | AGRANT◆ | 828,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 5, 2025 | RLMD | Relmada Therapeutics, INC. | PBUY | 500,000 | $2.20 | $1.1M | +173.4% | Open the original filing on SEC.gov |
| Jun 26, 2025 | RLMD | Relmada Therapeutics, INC. | AGRANT◆ | 600,000 | — | — | — | Open the original filing on SEC.gov |
| May 20, 2025 | RLMD | Relmada Therapeutics, INC. | PBUY | 60,000 | $0.5237 | $31.4K | +26.3% | Open the original filing on SEC.gov |
| May 19, 2025 | RLMD | Relmada Therapeutics, INC. | PBUY | 90,000 | $0.4854 | $43.7K | +65.1% | Open the original filing on SEC.gov |
| May 16, 2025 | RLMD | Relmada Therapeutics, INC. | PBUY | 50,000 | $0.442 | $22.1K | +56.6% | Open the original filing on SEC.gov |